Ikarian Capital, LLC

Source: SEC Form 13F · as of Mar 2026

Ikarian Capital, LLC holds 87 biotech & pharma companies tracked by BioSniper, totaling $849.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

87

Total value held

$849.6M

CompanySharesValue
TERNTerns Pharmaceuticals, Inc.2,656,378$140.0M
CYTKCYTOKINETICS INC1,242,472$81.9M
KODKodiak Sciences Inc.1,365,795$52.1M
ABVXAbivax SA350,935$38.9M
ALMSALUMIS INC.1,478,148$32.6M
BMYBRISTOL MYERS SQUIBB CO500,000$30.3M
CAPRCAPRICOR THERAPEUTICS, INC.878,015$26.7M
RVMDREVOLUTION MEDICINES, INC.258,142$25.1M
PCVXVaxcyte, Inc.428,682$24.9M
PRAXPraxis Precision Medicines, Inc.71,581$23.1M
ANIPANI PHARMACEUTICALS INC297,085$22.8M
RLMDRELMADA THERAPEUTICS, INC.2,688,359$18.7M
CLDXCelldex Therapeutics, Inc.575,247$18.2M
IONSIONIS PHARMACEUTICALS INC239,138$18.0M
OLMAOlema Pharmaceuticals, Inc.1,148,081$17.1M
BBIOBridgeBio Pharma, Inc.218,620$16.2M
NVONovo Nordisk A/S400,000$14.7M
PHVSPharvaris N.V.486,856$13.8M
DRUGBRIGHT MINDS BIOSCIENCES INC.166,647$12.2M
ORKAOruka Therapeutics, Inc.242,021$11.9M
MAZEMaze Therapeutics, Inc.393,399$11.7M
ANROAlto Neuroscience, Inc.515,000$11.6M
SLNOSOLENO THERAPEUTICS INC344,123$11.5M
VERAVera Therapeutics, Inc.271,700$10.9M
RAREUltragenyx Pharmaceutical Inc.482,571$10.1M
DMRADamora Therapeutics, Inc.335,710$8.7M
AVTXAvalo Therapeutics, Inc.560,000$8.4M
PVLAPALVELLA THERAPEUTICS, INC.64,626$8.1M
FULCFulcrum Therapeutics, Inc.1,049,161$8.0M
IVAInventiva S.A.1,429,101$7.8M
JBIOJade Biosciences, Inc.512,349$7.2M
ZURAZura Bio Ltd1,193,492$7.1M
OVIDOvid Therapeutics Inc.2,894,704$6.4M
LLYELI LILLY & Co6,547$6.0M
SRZNSurrozen Inc.173,107$5.0M
TECXTectonic Therapeutic, Inc.157,537$4.9M
ALECAlector, Inc.2,082,606$4.5M
KYMRKymera Therapeutics, Inc.50,400$4.2M
LEGNLegend Biotech Corp226,888$4.1M
ARVNARVINAS, INC.358,257$3.8M
CMPSCOMPASS Pathways plc675,000$3.7M
ARWRARROWHEAD PHARMACEUTICALS, INC.57,500$3.6M
BHVNBiohaven Ltd.412,481$3.5M
IVVDInvivyd, Inc.2,656,570$3.5M
ELVNEnliven Therapeutics, Inc.83,700$3.3M
ANNXAnnexon, Inc.580,244$3.2M
FBRXForte Biosciences, Inc.118,972$3.1M
VIRVir Biotechnology, Inc.293,258$2.6M
CABACabaletta Bio, Inc.900,000$2.4M
BBOTBridgeBio Oncology Therapeutics, Inc.270,231$2.4M
NUVLNuvalent, Inc.23,594$2.4M
JAZZJazz Pharmaceuticals plc12,460$2.4M
REPLReplimune Group, Inc.300,000$2.3M
TARSTarsus Pharmaceuticals, Inc.31,166$2.2M
SLDBSolid Biosciences Inc.264,409$1.9M
QUREuniQure N.V.91,060$1.5M
PEPGPepGen Inc.747,165$1.3M
DERMJourney Medical Corp251,436$1.2M
VSTMVerastem, Inc.213,865$1.1M
DFTXDefinium Therapeutics Inc.58,803$1.1M
STIMNeuronetics Inc.701,182$1.0M
LYELLyell Immunopharma, Inc.41,081$824K
KZRKezar Life Sciences, Inc.102,211$758K
CNTACentessa Pharmaceuticals plc18,113$719K
KALVKalVista Pharmaceuticals, Inc.35,119$707K
PMNProMIS Neurosciences Inc.55,000$699K
INSMINSMED Inc4,214$689K
HELPCYBIN INC.132,153$634K
ACADACADIA PHARMACEUTICALS INC28,099$625K
WVEWave Life Sciences Ltd.85,285$618K
EQEquillium, Inc.303,555$607K
GUTSFractyl Health Inc.1,100,000$504K
PALIPALISADE BIO, INC.274,978$481K
IMTXImmatics N.V.48,569$478K
VKTXViking Therapeutics, Inc.9,717$316K
SGMOSANGAMO THERAPEUTICS, INC1,218,671$301K
LXRXLEXICON PHARMACEUTICALS, INC.164,674$257K
ANLAdlai Nortye Ltd.33,899$235K
MGNXMACROGENICS INC74,893$216K
VYGRVoyager Therapeutics, Inc.53,063$205K
SNSESensei Biotherapeutics, Inc.6,351$200K
VYNEVYNE Therapeutics Inc.264,912$158K
RNACCartesian Therapeutics, Inc.20,807$128K
PMVPPMV Pharmaceuticals, Inc.89,136$111K
CMPXCompass Therapeutics, Inc.18,000$95K
RZLTRezolute, Inc.16,479$50K
JSPRJasper Therapeutics Inc.24,093$21K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Ikarian Capital, LLC — Biotech 13F Holdings & Portfolio | BioSniper